Skip to main content

Advertisement

Log in

False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases

  • Case Report
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

We report two cases of 18F-fluorodeoxyglucose positron emission tomography–computed tomography (FDG PET–CT) fusion imaging showing false-positive findings of bone metastases from esophagogastric cancer. Although multiple bone metastases from esophagogastric cancer were suggested by several images, ultimately, degeneration of the bone marrow was diagnosed histologically. We discuss the value of imaging modalities and the importance of a comprehensive diagnosis based on a combination of physical examination, laboratory test results, and imaging studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5.

    Article  PubMed  CAS  Google Scholar 

  2. Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gastric Cancer. 2011;11:38–45.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg. 1983;13:173–6.

    Article  PubMed  CAS  Google Scholar 

  4. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med. 2000;30:150–85.

    Article  PubMed  CAS  Google Scholar 

  5. Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148–56.

    Article  PubMed  Google Scholar 

  6. Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, et al. Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol. 1996;23:693–7.

    Article  PubMed  CAS  Google Scholar 

  7. Ohta M, Tokuda Y, Suzuki Y, Kubota M, Makuuchi H, Tajima T, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun. 2001;22:875–9.

    Article  PubMed  CAS  Google Scholar 

  8. Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med. 1994;19:13–4.

    Article  PubMed  CAS  Google Scholar 

  9. Hironaka SI, Boku N, Ohtsu A, Nagashima F, Sano Y, Muto M, et al. Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with bone metastasis. Gastric Cancer. 2000;3:19–23.

    Article  PubMed  Google Scholar 

  10. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET–CT. N Engl J Med. 2009;361:32–9.

    Article  PubMed  CAS  Google Scholar 

  11. Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, et al. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res. 2005;25:4439–44.

    PubMed  Google Scholar 

  12. Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med. 2003;44:690–9.

    PubMed  CAS  Google Scholar 

  13. Nakamoto Y, Osman M, Wahl RL. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Clin Nucl Med. 2003;28:302–7.

    PubMed  Google Scholar 

  14. Rosen RS, Fayad L, Wahl RL. Increased 18F-FDG uptake in degenerative disease of the spine: characterization with 18F-FDG PET/CT. J Nucl Med. 2006;47:1274–80.

    PubMed  CAS  Google Scholar 

  15. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375–9.

    PubMed  CAS  Google Scholar 

  16. Nakajima Y, Ohta S, Okada T, Miyawaki Y, Hoshino A, Suzuki T, et al. Osteoplastic bone metastasis in esophageal squamous cell cancer: report of a case. Surg Today. 2012;42:376–81.

    Article  PubMed  Google Scholar 

  17. Yang HL, Liu T, Wang XM, Xu Y, Deng SM. Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. Eur Radiol. 2011;21:2604–17.

    Article  PubMed  Google Scholar 

  18. Vogler JB 3rd, Murphy WA. Bone marrow imaging. Radiology. 1988;168:679–93.

    Article  PubMed  Google Scholar 

  19. Chen WT, Shih TT, Chen RC, Lo SY, Chou CT, Lee JM, et al. Vertebral bone marrow perfusion evaluated with dynamic contrast-enhanced MR imaging: significance of aging and sex. Radiology. 2001;220:213–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

Satoshi Ida and his co-authors have no conflicts of interest to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideo Baba.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ida, S., Watanabe, M., Yamao, T. et al. False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases. Surg Today 44, 2191–2194 (2014). https://doi.org/10.1007/s00595-014-0947-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-014-0947-8

Keywords

Navigation